BMRN vs KNTK · P/E 40, rev $1.76B vs P/E 18, rev $991.4M
Biomarin Pharmaceutical Inc (BMRN) versus Kinetik Holdings Inc (KNTK) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Kinetik Holdings Inc (KNTK) is a oil & gas midstream company listed on US.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported KNTK revenue for 2026-06-30 was $991.4M. Net income was $47.9M. KNTK currently screens at market cap $7.55B and trailing P/E 18.0.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. KNTK currently screens at market cap $7.55B and trailing P/E 18.0.
Not investment advice. Open the BMRN and KNTK stock pages for the full models.
Not investment advice.